All of the following statements regarding Octreotide is TRUE, EXCEPT:
**Core Concept**
Octreotide is a synthetic somatostatin analogue used in the management of various conditions, including acromegaly, carcinoid syndrome, and severe diarrhea. It mimics the action of natural somatostatin by inhibiting the release of various hormones and growth factors.
**Why the Correct Answer is Right**
Octreotide works by binding to somatostatin receptors on the surface of target cells, which triggers a cascade of intracellular signaling events that ultimately lead to the inhibition of hormone secretion. This is particularly useful in conditions where excessive hormone production is a key pathophysiological feature. Octreotide is also used to manage symptoms associated with certain types of tumors, such as carcinoid syndrome.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is a potential indication for octreotide, as it is often used to manage symptoms associated with carcinoid syndrome, including flushing and diarrhea.
**Option B:** This option is also a potential indication for octreotide, as it is sometimes used to manage severe diarrhea in patients with gastrointestinal disorders.
**Option C:** This is the correct answer, as octreotide is not used to treat hypoglycemia. In fact, octreotide can actually worsen hypoglycemia by inhibiting insulin secretion and promoting glucagon release.
**Clinical Pearl / High-Yield Fact**
It's worth noting that octreotide can cause gallstones as a side effect, particularly with long-term use. This is due to its effect on gallbladder motility and bile composition.
**Correct Answer: C. Octreotide is not used to treat hypoglycemia.